ketosis_and_diabetic_ketoacidosis_in_response_to_sglt2_inhibitors_basic_mechanisms_and_therapeutic_perspectives.d.酮症和糖尿病酮症酸中毒sglt2抑制剂的基本机制和治疗前景。_Image_Marked.pdf
- 1、本文档共28页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
ketosis_and_diabetic_ketoacidosis_in_response_to_sglt2_inhibitors_basic_mechanisms_and_therapeutic_perspectives.d.酮症和糖尿病酮症酸中毒sglt2抑制剂的基本机制和治疗前景。_Image_Marked
Ketosis and Diabetic Ketoacidosis in Response to SGLT2 Inhibitors:
Basic Mechanisms and Therapeutic Perspectives
Hongyu Qiu, MD1,2, Aleksandra Novikov, MD2,3, and Volker Vallon, MD2,3*
1 Department of Nephrology, West China Hospital, Sichuan University, Chengdu Sichuan, P.
R. China
2 Division of Nephrology Hypertension, Departments of Medicine and Pharmacology,
University of California San Diego, La Jolla, California 92093
3 VA San Diego Healthcare System, San Diego, California 92161
Running head: SGLT2 inhibition and ketoacidosis
Corresponding author:
Volker Vallon, MD
UC San Diego and VA San Diego Healthcare System
3350 La Jolla Village Dr. (9151)
San Diego, CA 92161
Phone: (001) 858-552-8585 ext 5945
Fax: (001) 858- 642-1438
E-mail: vvallon@
This article has been accepted for publication and undergone full peer review but has not been
through the copyediting, typesetting, pagination and proofreading process which may lead to
differences between this version and the Version of Record. Please cite this article as doi:
10.1002/dmrr.2886
This article is protected by copyright. All rights reserved.
Abstract
Inhibitors of the sodium-glucose cotransporter SGLT2 are a new class of
anti-hyperglycemic drugs that have been approved for the treatment of type 2 diabetes mellitus
(T2DM). These drugs inhibit glucose reabsorption in the proximal tubules of the kidney
thereby enhancing glucosuria and lowering blood glucose levels. Additional consequences and
benefits include a reduction in body weight, uric acid levels, and blood pressure. Moreover,
SGLT2 inhibition can have protective effects on the kidney and cardiovascular system in
patients with T2DM and high cardiovascular risk. However, a potential side effect that has
been reported with SGLT2 inhibitors in patients with T2DM and particularly during off-label
use in patients with type 1 diabetes is diabetic ketoacidosis
您可能关注的文档
- 酒店管理会所:会员制营销的核心观点_Image_Marked.pdf
- 软体家具生产项目的质量管理研究_Image_Marked.pdf
- 罗克韦尔AB_模拟量IO模块_用户手册中文高清版_Image_Marked.pdf
- 雷达原理课件第1章_雷达概论_Image_Marked.pdf
- 美地行:国际旅游地产规划案例赏析——世界四大度假小镇_Image_Marked.pdf
- 跨部门沟通及80后员工管理_Image_Marked.pdf
- 考前必备:信用社考试复习_全._Image_Marked.pdf
- 考试点专业课:西北工业大学_信号与系统本科习题精解_Image_Marked.pdf
- 鄂西北农副土特产品交易中心项目可行性分析报告_Image_Marked.pdf
- 考研有机化学试题及答案_Image_Marked.pdf
- 中考语文复习专题二整本书阅读课件.ppt
- 中考语文复习积累与运用课件.ppt
- 2025年初中学业水平考试模拟试题(二)课件.ppt
- 四川省2015届理科综合试题48套第12套.pdf
- 【课件】战争与和平—美术作品反映战争+课件-2024-2025学年高中美术湘美版(2019)美术鉴赏.pptx
- 【课件】青春牢筑国家安全防线 课件 2024-2025学年高中树立总体国家安全观主题班会.pptx
- 【课件】原始人的创造+课件高中美术湘美版(2019)美术鉴赏.pptx
- 上海证券-美容护理行业周报:流量加快去中心化,强运营头部品牌影响较小 -2024-.pdf
- T_CSEIA 1005—2023_能源工业互联网平台数据治理要求.pdf
- T_CDSA 504.16-2023_急流救援技术培训与考核要求.pdf
文档评论(0)